Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
about
KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathwaysSphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast couplingIdentification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiationPotassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal diseaseAn inducible, ligand-independent receptor activator of NF-κB gene to control osteoclast differentiation from monocytic precursorsNuclear factor kappaB p65 phosphorylation in orthodontic tooth movementMolecules and signaling pathways involved in the expression of OC-STAMP during osteoclastogenesisRole of CrkII Signaling in RANKL-Induced Osteoclast Differentiation and Function.Elucidation of CPX-1 involvement in RANKL-induced osteoclastogenesis by a proteomics approach.Akt1 in osteoblasts and osteoclasts controls bone remodeling.Periploca forrestii saponin ameliorates CIA via suppressing proinflammatory cytokines and nuclear factor kappa-B pathways.Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1.Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1beta-stimulated osteoclast differentiation through downregulation of MAPKs, c-Fos and NFATc1Strontium-loaded titania nanotube arrays repress osteoclast differentiation through multiple signalling pathways: In vitro and in vivo studiesAkt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effectsConvergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclastsCdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function.M-CSF potently augments RANKL-induced resorption activation in mature human osteoclastsTRP14 inhibits osteoclast differentiation via its catalytic activityIntermittent hypoxia effect on osteoclastogenesis stimulated by neuroblastoma cells.The study of mechanisms of protective effect of Rg1 against arthritis by inhibiting osteoclast differentiation and maturation in CIA mice2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexesMyostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.Methanol Extract of Croton Pycnanthus Benth. Inhibits Osteoclast Differentiation by Suppressing the MAPK and NF-κB Signaling PathwaysPeroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3Direct transcriptional targets of sex steroid hormones in bone.Novel functions for NFκB: inhibition of bone formationInhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.RNA therapeutics targeting osteoclast-mediated excessive bone resorption.Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast FunctionSignal peptide mutations in RANK prevent downstream activation of NF-κB.Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis.Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways.FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC.Hwangryun-Haedok-Tang Fermented with Lactobacillus casei Suppresses Ovariectomy-Induced Bone Loss.Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
P2860
Q21090734-407CAC5E-FEF1-4F5E-B1C2-55BBE6D4E949Q24319108-C85D3074-C939-48BE-AC5A-13275EA3A220Q24657159-EC6DE4D1-7A03-4CFC-B657-573543E3AD62Q28252713-C3D76BB6-C2F4-4625-A41C-67AE542FDC14Q28538066-17075B07-261A-46F0-B3D9-917AA0978A51Q28567113-39E00EFA-C78C-4B9B-A923-6961ACB514F0Q28592329-0A803951-11D4-4CBA-BDD4-6DEC81CEF659Q30009052-49B1ABE4-D780-4B9F-BB63-8C04538DFFC4Q33201894-BF7606B1-1F7F-41EF-A64B-B1DC045A1018Q33303666-7C471B09-14A9-4030-A47F-D100ABFC3CD2Q33626416-7CBBAE2B-918F-4611-913E-420C2D34A76DQ33648289-EE7AC9BC-1B27-43FA-A833-1A8AA8F37CEEQ33691655-792CA6EB-C79F-49D5-9CE3-53814E8D7FECQ33725776-065D5A2E-ECDA-4781-88DB-8F39D8AC6F68Q33744734-AA5CD3AF-9D06-4484-A440-790B3ADDB69BQ33850016-BC9FE2F7-6662-45AC-A6D1-CDD99DB099E1Q33882828-F0079A63-FC1D-4515-B502-D10E283114DCQ33919462-2594FEF0-A65B-4057-B26B-A98346F3CE6CQ33954930-5F31A044-12E9-4E82-B1CD-990C6E8E4D66Q34056632-8809E9EF-5D7D-4879-B9AE-B2DAC3AD2021Q34078699-2BB3A171-582A-4B3C-B60F-DFA257A57382Q34152121-A0D1C637-A81C-4AFB-BB3B-EAB6F49A36CCQ34339766-331382B0-001C-46E1-9D7A-73B66F7CD3E8Q34488033-26D90266-EFAD-4EF0-953D-3A181E889E53Q34602557-12ADDD88-DA48-4377-BACB-34C994E783A9Q34627979-D04E8378-67E5-4BED-B2FE-7065DE08F2FBQ34729815-61CE8AD3-7A19-45A2-B03C-9CC199564D66Q34758078-23C258EF-8220-4C8D-A184-4FDAAD1D455BQ34806538-03E5A04B-FE1E-4C97-B18C-89EBE922E14CQ35193656-564A3A6C-AA35-4EC6-829B-CD4B0F65CF1EQ35588952-05D0F9B6-D755-4401-B2C8-576CE97DBA34Q35800463-CD549811-CD9C-4EB4-B2CE-0025D7918BFEQ35953074-1CBC7D54-3792-42DA-BA5D-4E62F1A054ECQ36043987-C2DA2F3B-E9FC-445D-A0FC-0B3B8FFD82BBQ36054631-CB7FD521-7C2B-481F-84C0-168DAFF3116CQ36120762-F610FB47-8FF6-4653-8F81-3BC91A72672CQ36248504-25267F86-A995-4F5A-ACED-39AC37966144Q36280893-6AB49292-8B36-42F0-B761-693C3B5637F0Q36307897-17C94D77-5E6C-4FD0-858D-51930DE50F2BQ36320978-BDDB6CB8-88F4-4268-AB3A-88CD751EA85C
P2860
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
@ast
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
@en
type
label
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
@ast
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
@en
prefLabel
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
@ast
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
@en
P1476
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
@en
P2093
Hong Hee Kim
Zang Hee Lee
P304
P356
10.1016/S0006-291X(03)00695-8
P407
P577
2003-05-01T00:00:00Z